HFE (gene)

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Not to be confused with hemochromatosis.
Hemochromatosis
Protein HFE PDB 1a6z.png
PDB rendering based on 1a6z.
Available structures
PDB Ortholog search: PDBe, RCSB
Identifiers
Symbols HFE ; HFE1; HH; HLA-H; MVCD7; TFQTL2
External IDs OMIM613609 MGI109191 HomoloGene88330 GeneCards: HFE Gene
RNA expression pattern
PBB GE HFE 211330 s at tn.png
PBB GE HFE 206086 x at tn.png
PBB GE HFE 206087 x at tn.png
More reference expression data
Orthologs
Species Human Mouse
Entrez 3077 15216
Ensembl ENSG00000010704 ENSMUSG00000006611
UniProt Q30201 P70387
RefSeq (mRNA) NM_000410 NM_010424
RefSeq (protein) NP_000401 NP_034554
Location (UCSC) Chr 6:
26.09 – 26.1 Mb
Chr 13:
23.7 – 23.71 Mb
PubMed search [1] [2]

Human hemochromatosis protein also known as the HFE protein is a protein which in humans is encoded by the HFE gene. The HFE gene is located on short arm of chromosome 6 at location 6p22.2. Unusually, the official gene symbol (HFE for High Iron Fe) is not an abbreviation of the official name (hemochromatosis).[1]

Function[edit]

The protein encoded by this gene is a membrane protein that is similar to MHC class I-type proteins and associates with beta-2 microglobulin (beta2M). It is thought that this protein functions to regulate circulating iron uptake by regulating the interaction of the transferrin receptor with transferrin.[2]

The HFE gene contains 7 exons spanning 12 kb.[3] The full-length transcript represents 6 exons.[4]

HFE protein is composed of 343 amino acids. There are several components, in sequence: a signal peptide (initial part of the protein), an extracellular transferrin receptor-binding region (α1 and α2), a portion that resembles immunoglobulin molecules (α3), a transmembrane region that anchors the protein in the cell membrane, and a short cytoplasmic tail.[3]

HFE expression is subjected to alternative splicing. The predominant HFE full-length transcript has ~4.2 kb.[5] Alternative HFE splicing variants may serve as iron regulatory mechanisms in specific cells or tissues.[5]

HFE is prominent in small intestinal absorptive cells,[6][7] gastric epithelial cells, tissue macrophages, and blood monocytes and granulocytes,[7][8] and the syncytiotrophoblast, an iron transport tissue in the placenta.[9]

Clinical significance[edit]

The iron storage disorder hereditary hemochromatosis (HHC) is an autosomal recessive genetic disorder that usually results from defects in this gene.

The mutation or polymorphism most commonly associated with hemochromatosis is p. C282Y. About 1/200 of people of Northern European origin have two copies of this variant; they, particularly males, are at high risk of developing hemochromatosis.[10]

Allele frequencies of HFE C282Y in ethnically diverse western European white populations are 5-14%[11][12] and in North American non-Hispanic whites are 6-7%.[13] C282Y exists as a polymorphism only in Western European white and derivative populations, although C282Y may have arisen independently in non-whites outside Europe.[14]

HFE H63D is cosmopolitan but occurs with greatest frequency in whites of European descent.[15][16] Allele frequencies of H63D in ethnically diverse western European populations are 10-29%.[17] and in North American non-Hispanic whites are 14-15%.[18]

At least 42 mutations involving HFE introns and exons have been discovered, most of them in persons with hemochromatosis or their family members.[19] Most of these mutations are rare. Many of the mutations cause or probably cause hemochromatosis phenotypes, often in compound heterozygosity with HFE C282Y. Other mutations are either synonymous or their effect on iron phenotypes, if any, has not been demonstrated.[19]

Interactions[edit]

The HFE protein interacts with the transferrin receptor TFRC.[20][21] Its primary mode of action is the regulation of the iron storage hormone hepcidin.[22]

Hfe knockout mice[edit]

It is possible to delete part or all of a gene of interest in mice (or other experimental animals) as a means of studying function of the gene and its protein. Such mice are called “knockouts” with respect to the deleted gene. Hfe is the mouse equivalent of the human hemochromatosis gene HFE. The protein encoded by Hfe is Hfe. Mice homozygous (two abnormal gene copies) for a targeted knockout of all six transcribed Hfe exons are designated Hfe−/−.[23] Iron-related traits of Hfe−/− mice, including increased iron absorption and hepatic iron loading, are inherited in an autosomal recessive pattern. Thus, the Hfe−/− mouse model simulates important genetic and physiologic abnormalities of HFE hemochromatosis.[23] Other knockout mice were created to delete the second and third Hfe exons (corresponding to α1 and α2 domains of Hfe). Mice homozygous for this deletion also had increased duodenal iron absorption, elevated plasma iron and transferrin saturation levels, and iron overload, mainly in hepatocytes.[24] Mice have also been created that are homozygous for a missense mutation in Hfe (C282Y). These mice correspond to persons with hemochromatosis who are homozygous for HFE C282Y. These mice develop iron loading that is less severe than that of Hfe−/− mice.[25]

HFE mutations and iron overload in other animals[edit]

Black rhinoceroses (Diceros bicornis) develop iron overload. To determine whether the HFE gene of black rhinoceroses has undergone mutation as an adaptive mechanism to improve iron absorption from iron-poor diets, Beutler et al. sequenced the entire HFE coding region of four species of rhinoceros (two browsing and two grazing species). Although HFE was well conserved across the species, numerous nucleotide differences were found between rhinoceros and human or mouse, some of which changed deduced amino acids. Only one allele, p.S88T in the black rhinoceros, was a candidate that might adversely affect HFE function. p.S88T occurs in a highly conserved region involved in the interaction of HFE and TfR1.[26]

References[edit]

  1. ^ "HGNC: HFE". 
  2. ^ "Entrez Gene: HFE hemochromatosis". 
  3. ^ a b Feder, JN; Gnirke, A; Thomas, W; Tsuchihashi, Z; Ruddy, DA; Basava, A; Dormishian, F; Domingo R, Jr; Ellis, MC; Fullan, A; Hinton, LM; Jones, NL; Kimmel, BE; Kronmal, GS; Lauer, P; Lee, VK; Loeb, DB; Mapa, FA; McClelland, E; Meyer, NC; Mintier, GA; Moeller, N; Moore, T; Morikang, E; Prass, CE; Quintana, L; Starnes, SM; Schatzman, RC; Brunke, KJ; Drayna, DT; Risch, NJ; Bacon, BR; Wolff, RK (August 1996). "A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis". Nature Genetics 13 (4): 399–408. PMID 8696333. 
  4. ^ Dorak, M.T. "HFE (hemochromatosis)". Atlas of Genetics and Cytogenetics in Oncology and Haematology. Retrieved 2015. 
  5. ^ a b Martins, R; Silva, B; Proença, D; Faustino, P (3 March 2011). "Differential HFE gene expression is regulated by alternative splicing in human tissues". PloS One 6 (3): e17542. PMID 21407826. 
  6. ^ Waheed, A; Parkkila, S; Saarnio, J; Fleming, RE; Zhou, XY; Tomatsu, S; Britton, RS; Bacon, BR; Sly, WS (16 February 1999). "Association of HFE protein with transferrin receptor in crypt enterocytes of human duodenum". Proceedings of the National Academy of Sciences of the United States of America 96 (4): 1579–84. PMID 9990067. 
  7. ^ a b Griffiths, WJ; Kelly, AL; Smith, SJ; Cox, TM (September 2000). "Localization of iron transport and regulatory proteins in human cells". QJM : Monthly Journal of the Association of Physicians 93 (9): 575–87. PMID 10984552. 
  8. ^ Parkkila, S; Parkkila, AK; Waheed, A; Britton, RS; Zhou, XY; Fleming, RE; Tomatsu, S; Bacon, BR; Sly, WS (April 2000). "Cell surface expression of HFE protein in epithelial cells, macrophages, and monocytes". Haematologica 85 (4): 340–5. PMID 10756356. 
  9. ^ Parkkila, S; Waheed, A; Britton, RS; Bacon, BR; Zhou, XY; Tomatsu, S; Fleming, RE; Sly, WS (25 November 1997). "Association of the transferrin receptor in human placenta with HFE, the protein defective in hereditary hemochromatosis". Proceedings of the National Academy of Sciences of the United States of America 94 (24): 13198–202. PMID 9371823. 
  10. ^ "Hemochromatosis". 
  11. ^ Porto, Graca; de Sousa, Maria (2000). Barton, James C.; Edwards, Corwin Q., eds. Variation of hemochromatosis prevalence and genotype in national groups. In: Hemochromatosis: Genetics, pathophysiology, diagnosis and treatment: Cambridge University Press. pp. 51–62. ISBN 0521593808. 
  12. ^ Ryan, E; O'Keane, C; Crowe, J (December 1998). "Hemochromatosis in Ireland and HFE". Blood Cells, Molecules & Diseases 24 (4): 428–32. PMID 9851896. 
  13. ^ Acton, RT; Barton, JC; Snively, BM; McLaren, CE; Adams, PC; Harris, EL; Speechley, MR; McLaren, GD; Dawkins, FW; Leiendecker-Foster, C; Holup, JL; Balasubramanyam, A; Hemochromatosis and Iron Overload Screening Study Research Investigators (2006). "Geographic and racial/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study". Ethnicity & Disease 16 (4): 815–21. PMID 17061732. 
  14. ^ Rochette, J; Pointon, JJ; Fisher, CA; Perera, G; Arambepola, M; Arichchi, DS; De Silva, S; Vandwalle, JL; Monti, JP; Old, JM; Merryweather-Clarke, AT; Weatherall, DJ; Robson, KJ (April 1999). "Multicentric origin of hemochromatosis gene (HFE) mutations". American Journal of Human Genetics 64 (4): 1056–62. PMID 10090890. 
  15. ^ Merryweather-Clarke, AT; Pointon, JJ; Shearman, JD; Robson, KJ (April 1997). "Global prevalence of putative haemochromatosis mutations". Journal of Medical Genetics 34 (4): 275–8. PMID 9138148. 
  16. ^ Merryweather-Clarke, AT; Pointon, JJ; Jouanolle, AM; Rochette, J; Robson, KJ (2000). "Geography of HFE C282Y and H63D mutations". Genetic Testing 4 (2): 183–98. PMID 10953959. 
  17. ^ Fairbanks, Virgil F. (2000). Barton, James C.; Edwards, Corwin Q., eds. Hemochromatosis: population genetics. In: Hemochromatosis: Genetics, pathophysiology, diagnosis and treatment. Cambridge University Press. pp. 42–50. ISBN 0521593808. 
  18. ^ Acton, RT; Barton, JC; Snively, BM; McLaren, CE; Adams, PC; Harris, EL; Speechley, MR; McLaren, GD; Dawkins, FW; Leiendecker-Foster, C; Holup, JL; Balasubramanyam, A; Hemochromatosis and Iron Overload Screening Study Research Investigators (2000). "Geographic and racial/ethnic differences in HFE mutation frequencies in the Hemochromatosis and Iron Overload Screening (HEIRS) Study". Ethnicity & Disease 16 (4): 815–21. PMID 17061732. 
  19. ^ a b Edwards, Corwin Q.; Barton, James C. (2014). Greer, John P.; Arber, Daniel A.; Glader, Bertil; List, Alan F.; Means, Robert T., Jr.; Paraskevas, Frixos; Rodgers, George M., eds. Hemochromatosis. In: Wintrobe's Clinical Hematology. Wolters Kluwer/Lippincott Williams & Wilkins. pp. 662–681. ISBN 9781451172683. 
  20. ^ Feder JN, Penny DM, Irrinki A, Lee VK, Lebrón JA, Watson N et al. (Feb 1998). "The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding". Proceedings of the National Academy of Sciences of the United States of America 95 (4): 1472–7. doi:10.1073/pnas.95.4.1472. PMC 19050. PMID 9465039. 
  21. ^ West AP, Bennett MJ, Sellers VM, Andrews NC, Enns CA, Bjorkman PJ (Dec 2000). "Comparison of the interactions of transferrin receptor and transferrin receptor 2 with transferrin and the hereditary hemochromatosis protein HFE". The Journal of Biological Chemistry 275 (49): 38135–8. doi:10.1074/jbc.C000664200. PMID 11027676. 
  22. ^ Nemeth E, Ganz T (2006). "Regulation of iron metabolism by hepcidin". Annual Review of Nutrition 26: 323–342. doi:10.1146/annurev.nutr.26.061505.111303. PMID 16848710. 
  23. ^ a b Zhou, XY; Tomatsu, S; Fleming, RE; Parkkila, S; Waheed, A; Jiang, J; Fei, Y; Brunt, EM; Ruddy, DA; Prass, CE; Schatzman, RC; O'Neill, R; Britton, RS; Bacon, BR; Sly, WS (3 March 1998). "HFE gene knockout produces mouse model of hereditary hemochromatosis". Proceedings of the National Academy of Sciences of the United States of America 95 (5): 2492–7. PMID 9482913. 
  24. ^ Bahram, S; Gilfillan, S; Kühn, LC; Moret, R; Schulze, JB; Lebeau, A; Schümann, K (9 November 1999). "Experimental hemochromatosis due to MHC class I HFE deficiency: immune status and iron metabolism". Proceedings of the National Academy of Sciences of the United States of America 96 (23): 13312–7. PMID 10557317. 
  25. ^ Levy, JE; Montross, LK; Cohen, DE; Fleming, MD; Andrews, NC (1 July 1999). "The C282Y mutation causing hereditary hemochromatosis does not produce a null allele". Blood 94 (1): 9–11. PMID 10381492. 
  26. ^ Beutler, E; West, C; Speir, JA; Wilson, IA; Worley, M (2001). "The hHFE gene of browsing and grazing rhinoceroses: a possible site of adaptation to a low-iron diet". Blood Cells, Molecules & Diseases 27 (1): 342–50. PMID 11358396. 

Further reading[edit]

  • Dorak MT, Burnett AK, Worwood M (Mar 2002). "Hemochromatosis gene in leukemia and lymphoma". Leukemia & Lymphoma 43 (3): 467–77. doi:10.1080/10428190290011930. PMID 12002748. 
  • Beutler E (May 2003). "The HFE Cys282Tyr mutation as a necessary but not sufficient cause of clinical hereditary hemochromatosis". Blood 101 (9): 3347–50. doi:10.1182/blood-2002-06-1747. PMID 12707220. 
  • Ombiga J, Adams LA, Tang K, Trinder D, Olynyk JK (Nov 2005). "Screening for HFE and iron overload". Seminars in Liver Disease 25 (4): 402–10. doi:10.1055/s-2005-923312. PMID 16315134. 
  • Distante S (2006). "Genetic predisposition to iron overload: prevalence and phenotypic expression of hemochromatosis-associated HFE-C282Y gene mutation". Scandinavian Journal of Clinical and Laboratory Investigation 66 (2): 83–100. doi:10.1080/00365510500495616. PMID 16537242. 
  • Zamboni P, Gemmati D (Jul 2007). "Clinical implications of gene polymorphisms in venous leg ulcer: a model in tissue injury and reparative process". Thrombosis and Haemostasis 98 (1): 131–7. doi:10.1160/th06-11-0625. PMID 17598005. 

External links[edit]